Yusuf Açıkgöz
Lokman Hekim Üniversitesi(TR)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer(2020)22 cited
- → Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer(2020)21 cited
- → Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options(2023)17 cited
- → Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?(2020)14 cited
- → Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma(2025)11 cited
- → The effect of chemotherapy on olfactory function and mucociliary clearance(2020)9 cited
- → Plasma Cell-Free DNA Levels in Children on Peritoneal Dialysis(2009)9 cited
- → KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer(2019)9 cited
- → Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index(2023)7 cited
- → “Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?(2021)7 cited